Unraveling the mechanism of action of thiazolidinediones

Journal of Clinical Investigation

Volumn 106, Issue 11, 2000, Pages 1305-1307

  Kahn, C Ronald ^a,b   Chen, Lihong ^a   Cohen, Shmuel E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CCAAT ENHANCER BINDING PROTEIN; CELL NUCLEUS RECEPTOR; CHOLESTEROL; DIPHTHERIA TOXOID; DNA; FATTY ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; ROSIGLITAZONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRIACYLGLYCEROL; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROMOTER REGION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

EID: 0033659881     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11705     Document Type: Note

References (26)

1. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats
2. Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
3. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
4. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
5. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells
6. Adipocyte fatty acid-binding protein: Regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent
7. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
8. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
9. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
10. Transcriptional regulation of adipogenesis
11. Insights into insulin resistance and type 2 diabetes from knockout mouse models
12. Diabetes mellitus (type II): Etiology and pathogenesis
13. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes
14. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
15. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction
16. Insulin signaling and action in fat cells: Associations with insulin resistance and type 2 diabetes
17. In vitro studies on the action of CS-045, a new antidiabetic agent
18. Free fatty acids and pathogenesis of type 2 diabetes mellitus
19. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
20. Targeted expression of a toxin gene to adipose tissue: Transgenic mice resistant to obesity
21. Life without white fat: A transgenic mouse
22. Troglitazone action is independent of adipose tissue
23. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
24. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
25. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
26. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice